Contact Us    855-RIA-PLAN (855-742-7526)

MRKR: Marker Therapeutics Inc Stock

By | July 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 70.62
Enterprise Value ($M) 21.91
Book Value ($M) 52.28
Book Value / Share 0.63
Price / Book 1.35
NCAV ($M) 31.75
NCAV / Share 0.38
Price / NCAV 2.22

Profitability (mra)
Return on Invested Capital (ROIC) -0.63
Return on Assets (ROA) -0.89
Return on Equity (ROE) -1.49

Liquidity (mrq)
Quick Ratio 6.25
Current Ratio 6.25

Balance Sheet (mrq) ($M)
Current Assets 51.41
Assets 71.94
Liabilities 19.66
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-26 13D/A New Enterprise Associates 16, L.P. 17.40 65.31
03-24 13D/A Leen Ann M. 2.89 -11.05
03-15 13D/A Eastern Capital LTD 5.00 -11.19

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-11-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2021-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2021-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2021-03-09 10-K Annual Report – 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2022-01-18 448,145 1,282,576 34.94
2022-01-13 51,952 258,012 20.14

(click for more detail)

(click for list of largest short owners)

Similar Companies
MOR – MorphoSys AG MORF – Morphic Holding Inc
MREO – Mereo BioPharma Group plc MRNA – Moderna Inc
MRNS – Marinus Pharmaceuticals Inc


Financial data and stock pages provided by
Fintel.io





2018/07/06
> Back to All Posts